Study Identifies Sequence That Drives Non-AUG Translation
Kansas State researchers found a motif that promotes translation at alternative start codons, with the regulator 5MP acting alongside eIF1.
Updated on Nov. 18, 2026 in Life Sciences

Researchers at Kansas State University identified a sequence motif called NAT1 that helps promote translation at non-AUG start codons in messenger RNA. The team also found that the regulatory protein 5MP suppresses this non-AUG translation alongside the factor eIF1.
Why it matters
Cells normally begin translating messenger RNA at the AUG start codon, so understanding alternative starting points helps explain how a single gene can yield varied proteins. Disrupted regulation of non-AUG translation is associated with increased activity of proteins linked to cell growth and migration, making these findings relevant to basic biology.
The evidence is a peer-reviewed molecular biology study published in Science Advances, with no quantitative comparator reported in the source. The study does not yet establish how widely the NAT1 motif operates across the human genome.
The players
Kansas State University
A public land-grant research university in Manhattan, Kansas, whose Division of Biology hosted the study.
Katsura Asano
A professor of biology at Kansas State University's Division of Biology who studies the regulation of protein translation.
The details
Cells typically begin translating messenger RNA at the start codon AUG, but noncanonical translation can begin at alternative locations using non-AUG start codons. The research team identified NAT1, a short GC-rich sequence near these alternative starting points, and examined how the protein 5MP suppresses translation at non-AUG codons working alongside eIF1.
Timeline
Phys.org published an article on the Kansas State research on November 18, 2026.
The Big Picture
The finding extends the established understanding that translation normally starts at AUG by identifying NAT1 as a motif that promotes alternative starts. It also adds to growing evidence that repeat-associated protein production diseases may depend on how these non-AUG sites are regulated.
The work is basic research with no near-term consumer product described in the source. Its practical value would emerge over time if the regulatory mechanism proves relevant to diseases involving repeat-associated protein production.
The takeaway
Cells rely on more than one starting point when reading their genetic code, and the balance between promoting and suppressing those alternative starts shapes which proteins get made. Readers following molecular biology can track how such regulatory details inform future disease research.
Further reading
For related background, explore Life Sciences coverage on how cells read their genetic instructions.
Source note: This article includes information reported by Phys.






